Affordable Access

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Authors
  • Wachtell, Kristian
  • Lehto, Mika
  • Gerdts, Eva
  • Olsen, Michael H
  • Hornestam, Björn
  • Dahlöf, Björn
  • Ibsen, Hans
  • Julius, Stevo
  • Kjeldsen, Sverre E
  • Lindholm, Lars H
  • Nieminen, Markku S
  • Devereux, Richard B
Type
Published Article
Journal
Journal of the American College of Cardiology
Publisher
Elsevier
Publication Date
Mar 01, 2005
Volume
45
Issue
5
Pages
712–719
Identifiers
PMID: 15734615
Source
Medline
License
Unknown

Abstract

Our novel finding is that new-onset AF and associated stroke were significantly reduced by losartan- compared to atenolol-based antihypertensive treatment with similar blood pressure reduction.

Report this publication

Statistics

Seen <100 times